OCAMPO CHRISTINE

CIK 00012801544 companiesALISO VIEJO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001280154

Recent Transactions

50 trades

Disposition to Issuer
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2021-03-29−133,500→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Common Shares
2021-03-29−9,810→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2021-03-29−3,750→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Common Shares
2021-03-29−68,971→ 0 total
Disposition to Issuer
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2021-03-29−70,000→ 0 total
Award
Urovant Sciences Ltd.
Common Shares
2020-05-01+44,346→ 77,179 total
Award
Urovant Sciences Ltd.
Common Shares
2020-01-07+32,833→ 32,833 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2019-01-06+70,000→ 70,000 total
Award
Urovant Sciences Ltd.
Stock Option (Right to Buy)
2018-10-15+3,750→ 3,750 total
Award
Eledon Pharmaceuticals, Inc.$ELDN
Stock Option (Right to Buy)
2017-05-24+52,500→ 52,500 total
Purchase
Eledon Pharmaceuticals, Inc.$ELDN
Common Stock
2017-05-10$9.99/sh+10,010→ 21,590 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-12-18$16.93/sh−5,780→ 108,797 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2014-12-16−17,500→ 0 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-12-16$2.59/sh+12,500→ 127,077 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-12-16$16.94/sh−12,500→ 132,077 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-12-16$4.18/sh+17,500→ 144,577 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (Right to Buy)
2014-12-16−12,500→ 17,500 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-12-16$16.94/sh−17,500→ 114,577 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-11-10+31,992→ 94,733 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-11-10+19,844→ 114,577 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-10-24$11.81/sh−2,080→ 77,791 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-09-15$9.45/sh−55,000→ 79,871 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to Buy)
2014-09-15−55,000→ 17,500 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-08-26$6.10/sh−2,110→ 79,871 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-02-12+29,325→ 92,527 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2014-02-12+15,050→ 107,577 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-12-18$2.63/sh−2,450→ 63,202 total
Award
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2013-12-13+17,250→ 17,250 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-05-15$0.88/sh+4,000→ 69,652 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-05-15$3.28/sh−57,700→ 65,652 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-05-15$3.29/sh−20,000→ 65,652 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-05-15$0.88/sh+15,000→ 84,652 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2013-05-15$0.88/sh+38,700→ 123,352 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2013-05-15+15,000→ 0 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2013-05-15+4,000→ 0 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2013-05-15+38,700→ 0 total
Award
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2012-12-17+32,500→ 32,500 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-12-17+21,288→ 76,689 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-12-17+8,963→ 85,652 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-12-03$2.55/sh−2,845→ 55,401 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-09-17$3.49/sh−65,000→ 58,246 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-09-17$0.53/sh+65,000→ 123,246 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Employee Stock Option (right to buy)
2012-09-17−65,000→ 65,000 total
Purchase
AVANIR PHARMACEUTICALS, INC.
Common Stock
2012-03-06$2.60/sh+3,000→ 3,000 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2011-12-15+6,250→ 44,496 total
Award
AVANIR PHARMACEUTICALS, INC.
Common Stock
2011-12-15+13,750→ 58,246 total
Award
AVANIR PHARMACEUTICALS, INC.
Stock Option (right to buy)
2011-12-15+90,000→ 90,000 total
Sale
AVANIR PHARMACEUTICALS, INC.
Common Stock
2011-12-02$2.38/sh−2,676→ 38,246 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Stock option (right to buy)
2011-11-11−64,500→ 38,700 total
Exercise/Conversion
AVANIR PHARMACEUTICALS, INC.
Common Stock
2011-11-11$1.20/sh+3,750→ 44,672 total

Companies

Recent Filings

Address

101 ENTERPRISE, SUITE 300

ALISO VIEJO, CA, 92656

View on SEC.gov